SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-023518
Filing Date
2022-11-09
Accepted
2022-11-09 07:31:06
Documents
13
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vera-20221109.htm   iXBRL 8-K 68813
2 EX-99.1 vera-ex99_1.htm EX-99.1 188121
  Complete submission text file 0000950170-22-023518.txt   389665

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vera-20221109.xsd EX-101.SCH 2446
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vera-20221109_lab.xml EX-101.LAB 13896
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vera-20221109_pre.xml EX-101.PRE 11355
7 EXTRACTED XBRL INSTANCE DOCUMENT vera-20221109_htm.xml XML 4896
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 221370673
SIC: 2834 Pharmaceutical Preparations